Search for Clinical Trial Results

Sponsored By

Adenocarcinoma, Follicular - 36 Studies Found

Status Study
Completed Study Name: Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131
Condition:
  • Recurrent Thyroid Cancer
  • Stage IVA Follicular Thyroid Cancer Date: 2004-06-10
    Interventions:
    • Drug: Decitabine Starting dose
Active, not recruiting Study Name: REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid Carcinomas
Condition: Thyroid Neoplasms
Date: 2006-02-03
Interventions: Drug: Lenalidomide Initial dose is 25 mg/day dose will be adjusted accordingly as needed. Dose range for
Not yet recruiting Study Name: Anaplastic Thyroid Cancer and Follicular Thyroid Cancer-derived Exosomal Analysis Via Treatment of Lovastatin and Vildagliptin and Pilot Prognostic Study Via Urine Exosomal Biological Markers in Thyroid Cancer Patients
Condition: Thyroid Cancer
Date: 2016-07-27
Completed Study Name: Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
Condition:
  • Insular Thyroid Cancer
  • Recurrent Thyroid Cancer
  • Stage II <
    Date: 2005-03-03
    Interventions: Drug: Bortezomib Administered IV at the dose of 1.3 mg/m^2 on a twice-weekly schedule for 2 consecutive
Active, not recruiting Study Name: Efficacy and Safety of Vandetanib (ZD6474) in Patients With Metastatic Papillary or Follicular Thyroid Cancer
Condition: Thyroid Neoplasms
Date: 2007-09-27
Interventions:
  • Drug: Vandetanib 300 mg oral o
Completed Study Name: Sutent Adjunctive Treatment of Differentiated Thyroid Cancer
Condition:
  • Papillary Thyroid Cancer
  • Follicular Thyroid Cancer
  • Date: 2008-04-25
    Interventions: Drug: SU011248, Sutent Sutent 37.5 mg/day will be given orally after radioactive iodine therapy. Total t
Completed Study Name: Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine
Condition:
  • Recurrent Thyroid Cancer
  • Stage IV Follicular Thyroid Cancer Date: 2004-12-08
    Interventions:
    • Drug: romidepsin Given IV
Suspended Study Name: Pre-Operative Nodal Staging of Thyroid Cancer Using Ultra-Small Superparamagnetic Iron Oxide Magnetic Resonance Imaging (USPIO MRI): Preliminary Study
Condition:
  • Papillary Carcinoma of Thyroid Metastatic to Regional Lymph Node
  • Metastatic Medullary Thyroi
    Date: 2013-08-20
    Interventions:
    • Drug: Ferumoxytol Ferumoxytol

Active, not recruiting Study Name: Dabrafenib With or Without Trametinib in Treating Patients With Recurrent Thyroid Cancer
Condition:
  • Follicular Thyroid Cancer
  • Insular Thyroid Cancer
  • Date: 2012-10-22
    Interventions:
    • Drug: dabrafenib 150 mg orally
Completed Study Name: A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors
Condition:
  • Papillary Thyroid Cancer
  • Follicular Thyroid Cancer
  • Date: 2010-03-22
    Interventions:
    • Drug: rosiglitazone one 4 mg d
Next >>>